EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 26 (2019) Parasite, 26 (2019) 70 Full HTML
Open Access
Review
Issue
Parasite
Volume 26, 2019
Article Number 70
Number of page(s) 6
DOI https://doi.org/10.1051/parasite/2019070
Published online 29 November 2019

© S.M. Moghaddam et al., published by EDP Sciences, 2019

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction

Cystic echinococcosis (CE) and alveolar echinococcosis (AE) are zoonotic infections caused by the larval stages (metacestodes) of parasitic cestodes Echinococcus granulosus and E. multilocularis [15, 17, 52]. Metacestodes are able to persist in intermediate hosts for a long period of time (over decades), without causing obvious pathologic damage in host tissues [52]. The most dangerous complication of echinococcosis is cyst perforation, leading to death from septic shock or embolic complications [2, 47, 57].

During CE, the cyst is created in the course of parasite maturation. Additionally, parasites can survive by developing cellular interactions with host tissues [51]. These specific interactions are probably facilitated by genetic heritage in the parasite from its mammalian hosts [6, 31, 50]. Chronic infections caused by the parasite depend on rich crosstalk with the host, which leads to an appropriate immune response and to the survival of both the host and the parasite [49] (Fig. 1).

thumbnail Figure 1

A summary of the potential mechanisms of cell death induced by Echinococcus spp. larval stage. The main molecules involved in cell death are shown, and the three main paths are shown with bold arrows. Directions for stimulation of necrosis, apoptosis and autophagy are shown. In the process of cell death caused by Echinococcus spp., apoptosis plays an important role in the cytolysis of the involved tissues. They can activate both extrinsic and intrinsic pathways. For example, some of them motivate mitochondria to release cytochrome C and P53, resulting in the formation of apoptosomes and activation of Caspase-3.

Apoptosis of E. granulosus protoscoleces was first identified more than a decade ago by a group of researchers from Chile [33]. The link between DNA repair via RAD9 and cyst infertility was documented in the same laboratory in 2008 [7]. Researchers from China and Iran later confirmed the involvement of apoptosis in hydatid cyst pathophysiology [18, 51]. This last study opens the discussion on a bi-functional effect in the relationship between host and parasite, leading to a complex process of cell death regulation during hydatid cyst development. It was shown that extracted hydatid cyst fluid (HCF) induced lymphocyte apoptosis in vitro, demonstrating a direct effect of the parasite on host immune cells. This crosstalk has opened new treatment opportunities in the last decade [1, 3, 5, 8, 10, 18].

The first approach is to consider the early development of a cyst from approximately 10 stem cells located inside an activated oncosphere in the liver, as a process mimicking cancer [21, 42]. Based on that assumption, one could speculate that anti-cancer therapeutic approaches, including radiotherapy, should be tested to induce regulated cell death (RCD) of the parasite [25]. The second option is to address the issue of pro-apoptotic effects of HCF produced during infection of the intermediate host, and to test the hypothesis of potential value of certain specific compounds of this fluid as therapeutic agents for human cancers, including melanoma and breast cancer [11, 14, 16, 39, 51]. These two approaches may open an extensive research area, provided preliminary results obtained to date are consolidated and confirmed in large controlled studies.

Regulated cell death of the Echinococcus parasite

Different proteins involved in a large array of cellular mechanisms, including cell survival, have recently been described at different stages of metacestode development [12, 48]. While there is no definitive evidence that the presence of these proteins may be linked to an effect on the RCD of the parasite, this paves the way for an interesting approach in parasite biology.

Prohibitin is a highly conserved protein involved in multiple functions depending on its localization, and is crucial for apoptosis processes in human cells [37]. E. granulosus prohibitin (EgPHB) was recently identified and characterized [59]. EgPHB showed an N-terminal hydrophobic transmembrane domain that could be involved in membrane anchorage. This EgPHB was detected in the parasite larva, germinal layer, and adult worm with overexpression in the germinal layer.

Tumor suppressor P53 has been widely studied in mammalian cells and its role in DNA repair and apoptosis is highly documented. A P53 analog (Emp53) has been identified and characterized in E. multilocularis [9]. While the sequence similarity with human P53 is low, Emp53 showed a DNA-binding domain with a tertiary structure similar to human P53, and it could bind to human P53 recognition sites. Authors demonstrated that increased apoptosis was induced in E. multilocularis when exposed to UV-C irradiation, providing evidence that Emp53 may control parasite apoptosis. Similar data are not available for E. granulosus, but considering the high degree of conservation of P53, further research may be successful.

Calmodulin is a protein activator that binds to many different proteins in a calcium-dependent and reversible manner [45]. Among the calmodulin-binding proteins, calcineurin has been found to be involved in apoptosis-related pathway initiation. Calmodulin was predicted as a potential drug target in E. multilocularis [54], and more recently identified and characterized in E. granulosus (Egcam) [56]. Egcam was shown to be expressed in the larva, germinal layer, and adult worm. While calmodulin is known to be involved in RCD, this was not explored in this study. The conservation and the expression of these proteins in Echinococcus parasites and their link with RCD subroutine was the starting point for future evidence of the role of RCD in these helminth parasites. This molecular and protein basis should be linked with the observation of apoptosis induction in cysts using medicinal and physical methods.

Naseri et al. (2016) demonstrated the pro-apoptotic effect on protoscoleces of albendazole sulfoxide and more soluble albendazole nanopolymeric particles using DNA fragmentation assays, scanning electron microscopy, and caspase-3 mRNA-expression [27]. One of the hallmarks of apoptosis and RCD is the activation of the caspase cascade, which could be detected in supernatants of activated cells. Shahnazi et al. (2017) have shown that incubation of cyst protoscoleces with an extract of 50 and 100 mg/mL of Myrtus communis (Myrtaceae), which has been empirically used in traditional medicine in Iran, led to caspase activation after 4 h at 37 °C [43]. Another group of researchers tested the effect of biliary acids on protoscoleces viability in vitro [46]. Using chenodeoxycholic acid at a concentration of 3 mM for 6 days in culture, they showed a 100% mortality rate of protoscoleces of E. granulosus. This effect was linked to increased caspase-3 activity.

However, in agreement with the hypothesis developed in this review, authors have tested the effect of radiotherapy for the treatment of CE in infected sheep [25]. While the same authors have previously demonstrated that X-ray treatment had a negative impact on the outcome of infected rodents [24], they tested the effect of 30, 45 and 60 Gy, divided into three doses, for 7 days on 20 infected female sheep. No significant adverse effects were detected during the 3-month follow-up. Irradiated cysts showed decreased fluid tension and partial collapse of the cystic wall. The expression of various genes during and after the treatment provided contradictory data, and no definitive conclusion can be drawn about the molecular basis of this clinical effect.

Regulated cell death induced by the Echinococcus parasite

The close relationship between Echinococcus metacestodes and the intermediate host has been extensively described by Brehm and Koziol [6]. This contact may lead to unexpected adverse effects, such as the pro or anti-cancer properties of some components of HCF. Based on the observation that HCF activates the MAPK signaling pathway in rat liver cells, authors tested its effect on melanoma cell line A375 [16]. Using MTT assays (3-[4,5-dimethylthiazol-2,5-diphenyl tetrazolium bromide]), propidium iodide and annexin-V staining and western blotting of various RCD proteins, it was demonstrated that HCF promotes the proliferation of melanoma A375 cells, and inhibits cell apoptosis [6].

Conversely, authors have shown that a member of the Kunitz type protease inhibitor family acts as an inhibitor of neutrophil elastase and chemotaxis. This molecule (EgKI-1) has been isolated from HCF. Recombinant EgKI-1 has been produced and its activity was tested against a range of human cancer cell lines, including breast adenocarcinoma, pharynx adenocarcinoma, cervical epithelial adenocarcinoma, and melanoma [11, 38, 40]. It was shown that EgKI-1 induced apoptosis in breast cancer cells after 24 h in a dose-dependent manner [39].

Conclusion

Although the cell death process is an answer to the question of how to determine the fate of dead cells, most of the interactions between Echinococcus and host tissues are associated with immune and pathologic conditions. The lack of satisfactory treatment for echinococcosis and the emergence of resistance to existing antibiotics [4, 19, 44] may raise the following question: is RCD a gateway to this parasite? Studies of the suicide genes involved in these pathways and the effects of various factors on their activity can help to identify new pharmacologic targets and improve treatment. Understanding the importance of these activations is critical because RCD is an integral part of health and disease and is stimulated by a variety of pathologic and physiologic stimuli. Histologic studies have shown that many factors are important for stimulating RCD in parasites and infected host cells [14, 35, 36]. A large number of studies have shown that the expression level of apoptosis-inducing factors in the germinal layer of sterile cysts is higher than that of fertile cysts, and the expression rate of anti-apoptotic factors in fertile cysts is higher, which may affect cystic infertility. Recently, much effort has been made to understand the mechanism of RCD and its regulation (Table 1). The recognition of cell death in different organisms and their effects on the host could pave the way to tailored therapies [20, 55]. Studying the effects of various factors on host and parasite apoptosis and identifying biochemical pathways are important steps in identifying new drug targets. Based on the current review, radiotherapy has the greatest impact on the apoptosis of hydatid cysts. Studying the pathologic pathways of cell death is also important to better understand the relationship between the host and the parasite, and the factors that alter this relationship. Factors that affect enzyme activity in hydatid cysts can be a way of inducing cystic infertility and preventing the spread of disease, particularly in the liver and lungs. The combination of these drugs may play an important role in the progressive RCD of cystic components. At the same time, hydatid cyst inhibitors that contribute to autophagy regulation have been identified, which is important to examine how the combined inputs of these regulatory circuits affect cell decisions that favor or oppose autophagy. Selective targeting of apoptosis to the germinal layer, changes in expression of apoptotic associated genes, and structural changes in various parts of the parasite can be an effective anti-echinococcosis mechanism.

Table 1

Cell death and host defense in hydatid cysts.

Acknowledgments

We would like to express our gratitude to Dr. A. Abdoli and Dr. F. Jadidi for their valuable and constructive comments.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Ahmadpour E, Godrati-Azar Z, Spotin A, Norouzi R, Hamishehkar H, Nami S, Heydarian P, Rajabi S, Mohammadi M, Perez-Cordon G. 2019. Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis. Parasites & Vectors, 12, 469. [CrossRef] [PubMed] [Google Scholar]
  2. Akbulut S. 2018. Parietal complication of the hydatid disease: comprehensive literature review. Medicine, 97(21), e10671. [CrossRef] [PubMed] [Google Scholar]
  3. Amirmajdi MM, Sankian M, Mashhadi IE, Varasteh A, Vahedi F, Sadrizadeh A, Spotin A. 2011. Apoptosis of human lymphocytes after exposure to hydatid fluid. Iranian Journal of Parasitology, 6(2), 9. [PubMed] [Google Scholar]
  4. Bakhtiar NM, Akbarzadeh A, Casulli A, Mahami-Oskouei M, Ahmadpour E, Nami S, Rostami A, Spotin A. 2019. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects. Parasitology Research, 1–12. [PubMed] [Google Scholar]
  5. Bienvenu A-L, Gonzalez-Rey E, Picot S. 2010. Apoptosis induced by parasitic diseases. Parasites & Vectors, 3(1), 106. [CrossRef] [PubMed] [Google Scholar]
  6. Brehm K, Koziol U. 2017. Echinococcus–host interactions at cellular and molecular levels. Advances in Parasitology, 147–212. [Google Scholar]
  7. Cabrera G, Cabrejos ME, Morassutti AL, Cabezón C, Orellana J, Hellman U, Zaha A, Galanti N. 2008. DNA damage, RAD9 and fertility/infertility of Echinococcus granulosus hydatid cysts. Journal of Cellular Physiology, 216(2), 498–506. [CrossRef] [PubMed] [Google Scholar]
  8. Cain K. 2003. Chemical-induced apoptosis: formation of the Apaf-1 apoptosome. Drug Metabolism Reviews, 35(4), 337–363. [CrossRef] [PubMed] [Google Scholar]
  9. Cheng Z, Zhu S, Wang L, Liu F, Tian H, Pengsakul T, Wang Y. 2015. Identification and characterisation of Emp53, the homologue of human tumor suppressor p53, from Echinococcus multilocularis: its role in apoptosis and the oxidative stress response. International Journal for Parasitology, 45(8), 517–526. [CrossRef] [PubMed] [Google Scholar]
  10. Czabotar PE, Lessene G, Strasser A, Adams JM. 2014. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nature Reviews Molecular Cell Biology, 15(1), 49–63. [CrossRef] [PubMed] [Google Scholar]
  11. Daneshpour S, Kefayat AH, Mofid MR, Rad SR, Darani HY. 2019. Effect of hydatid cyst fluid antigens on induction of apoptosis on breast cancer cells. Advanced Biomedical Research, 8, 27. [CrossRef] [PubMed] [Google Scholar]
  12. Díaz Á. 2017. Immunology of cystic echinococcosis (hydatid disease). British Medical Bulletin, 124(1), 121–133. [PubMed] [Google Scholar]
  13. Díaz A, Irigoín F, Ferreira F, Sim RB. 1999. Control of host complement activation by the Echinococcus granulosus hydatid cyst. Immunopharmacology, 42(1–3), 91–98. [CrossRef] [PubMed] [Google Scholar]
  14. El-Aal AAA, El-Gebaly NSM, Al-Antably AS, Hassan MA, El-Dardiry MA. 2016. Post-immunization immunohistochemical expression of Caspase 3 and p53 apoptotic markers in experimental hydatidosis. Revista Brasileira de Parasitologia Veterinária, 25(3), 333–340. [CrossRef] [Google Scholar]
  15. Flisser A. 2018. Eliminating cystic echinococcosis in the 21st century. Lancet Infectious Diseases, 18(7), 703–704. [CrossRef] [Google Scholar]
  16. Gao X-Y, Zhang G-H, Huang L. 2018. Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus. OncoTargets and Therapy, 11, 1447. [CrossRef] [PubMed] [Google Scholar]
  17. Hajizadeh M, Ahmadpour E, Sadat ATE, Spotin A. 2013. Hydatidosis as a cause of acute appendicitis: a case report. Asian Pacific Journal of Tropical Disease, 3(1), 71–73. [Google Scholar]
  18. Hu H, Kang J, Chen R, Mamuti W, Wu G, Yuan W. 2011. Drug-induced apoptosis of Echinococcus granulosus protoscoleces. Parasitology Research, 109(2), 453–459. [CrossRef] [PubMed] [Google Scholar]
  19. Kohansal MH, Nourian A, Rahimi MT, Daryani A, Spotin A, Ahmadpour E. 2017. Natural products applied against hydatid cyst protoscolices: a review of past to present. Acta Tropica, 176, 385–394. [CrossRef] [PubMed] [Google Scholar]
  20. Kourtis N, Tavernarakis N. 2009. Autophagy and cell death in model organisms. Cell Death and Differentiation, 16(1), 21. [CrossRef] [PubMed] [Google Scholar]
  21. Koziol U, Brehm K. 2015. Recent advances in Echinococcus genomics and stem cell research. Veterinary Parasitology, 213(3–4), 92–102. [CrossRef] [PubMed] [Google Scholar]
  22. Loos JA, Caparros PA, Nicolao MC, Denegri GM, Cumino AC. 2014. Identification and pharmacological induction of autophagy in the larval stages of Echinococcus granulosus: an active catabolic process in calcareous corpuscles. International Journal for Parasitology, 44(7), 415–427. [CrossRef] [PubMed] [Google Scholar]
  23. Loos JA, Dávila VA, Rodrígues CR, Petrigh R, Zoppi JA, Crocenzi FA, Cumino AC. 2017. Metformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosis. PLoS Neglected Tropical Diseases, 11(2), e0005370. [CrossRef] [PubMed] [Google Scholar]
  24. Mao R, Wu G, Wang H, Lu P, Li J, Li H, Ainiwaer A, Bai Y, Shu M, Bao Y. 2017. Effects of X-ray on the metacestodes of Echinococcus granulosus in vitro. BMC Infectious Diseases, 17(1), 636. [CrossRef] [PubMed] [Google Scholar]
  25. Mao R, Zhang W-B, Qi H-Z, Jiang T, Wu G, Lu P-F, Ainiwaer A, Shang G, Xu L, Hao J. 2017. Efficacy of radiotherapy for the treatment of cystic echinococcosis in naturally infected sheep. Infectious Diseases of Poverty, 6(1), 88. [CrossRef] [PubMed] [Google Scholar]
  26. Miller AH, Raison CL. 2016. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22–34. [CrossRef] [PubMed] [Google Scholar]
  27. Naseri M, Akbarzadeh A, Spotin A, Akbari NAR, Mahami-Oskouei M, Ahmadpour E. 2016. Scolicidal and apoptotic activities of albendazole sulfoxide and albendazole sulfoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces. Parasitology Research, 115(12), 4595–4603. [CrossRef] [PubMed] [Google Scholar]
  28. Ni X, Yan H, Lou Z, Jia W. 2012. The signaling systems in Echinococcus multilocularis. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese Journal of Parasitology & Parasitic Diseases, 30(3), 233–237. [PubMed] [Google Scholar]
  29. Nicolao MC, Loos JA, Rodrigues CR, Beas V, Cumino AC. 2017. Bortezomib initiates endoplasmic reticulum stress, elicits autophagy and death in Echinococcus granulosus larval stage. PLoS One, 12(8), e0181528. [CrossRef] [PubMed] [Google Scholar]
  30. Nono JK, Pletinckx K, Lutz MB, Brehm K. 2012. Excretory/secretory-products of Echinococcus multilocularis larvae induce apoptosis and tolerogenic properties in dendritic cells in vitro. PLoS Neglected Tropical Diseases, 6(2), e1516. [CrossRef] [PubMed] [Google Scholar]
  31. Noori J, Spotin A, Ahmadpour E, Mahami-Oskouei M, Sadeghi-Bazargani H, Kazemi T, Sakhinia E, Aghebati-Maleki L, Shahrivar F. 2018. The potential role of toll-like receptor 4 Asp299Gly polymorphism and its association with recurrent cystic echinococcosis in postoperative patients. Parasitology Research, 117(6), 1717–1727. [CrossRef] [PubMed] [Google Scholar]
  32. Pan W, Hao W-T, Shen Y-J, Li X-Y, Wang Y-J, Sun F-F, Yin J-H, Zhang J, Tang R-X, Cao J-P. 2017. The excretory-secretory products of Echinococcus granulosus protoscoleces directly regulate the differentiation of B10, B17 and Th17 cells. Parasites & Vectors, 10(1), 348. [CrossRef] [PubMed] [Google Scholar]
  33. Paredes R, Jimenez V, Cabrera G, Iragüen D, Galanti N. 2007. Apoptosis as a possible mechanism of infertility in Echinococcus granulosus hydatid cysts. Journal of Cellular Biochemistry, 100(5), 1200–1209. [CrossRef] [PubMed] [Google Scholar]
  34. Pasparakis M, Vandenabeele P. 2015. Necroptosis and its role in inflammation. Nature, 517(7534), 311–320. [CrossRef] [PubMed] [Google Scholar]
  35. Pavlova A, Delev D, Lacroix-Desmazes S, Schwaab R, Mende M, Fimmers R, Astermark J, Oldenburg J. 2009. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A. Journal of Thrombosis and Haemostasis, 7(12), 2006–2015. [CrossRef] [Google Scholar]
  36. Pearson C, van Ewijk W, McDevitt H. 1997. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. Journal of Experimental Medicine, 185(4), 583–600. [CrossRef] [Google Scholar]
  37. Peng Y-T, Chen P, Ouyang R-Y, Song L. 2015. Multifaceted role of prohibitin in cell survival and apoptosis. Apoptosis, 20(9), 1135–1149. [CrossRef] [PubMed] [Google Scholar]
  38. Ranasinghe SL, Boyle GM, Fischer K, Potriquet J, Mulvenna JP, McManus DP. 2018. Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising anti-cancer therapeutic. BioRxiv, 357590. [Google Scholar]
  39. Ranasinghe SL, Boyle GM, Fischer K, Potriquet J, Mulvenna JP, McManus DP. 2018. Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer. PLoS One, 13(8), e0200433. [CrossRef] [PubMed] [Google Scholar]
  40. Ranasinghe SL, McManus DP. 2018. Echinococcus granulosus: cure for cancer revisited. Frontiers in Medicine, 5, 60. [CrossRef] [PubMed] [Google Scholar]
  41. Rekhi B. 2012. Cytomorphological spectrum of hydatidosis with eosinophilia, clinically mimicking a malignancy: an uncommon presentation. Journal of Cytology, 29(1), 48–50. [CrossRef] [PubMed] [Google Scholar]
  42. Segura-Trepichio M, Montoza-Nuñez JM, Candela-Zaplana D, Herrero-Santacruz J, Pla-Mingorance F. 2016. Primary sacral hydatid cyst mimicking a neurogenic tumor in chronic low back pain: case report and review of the literature. Journal of Neurosciences in Rural Practice, 7(Suppl 1), S112–S116. [CrossRef] [PubMed] [Google Scholar]
  43. Shahnazi M, Azadmehr A, Jondabeh MD, Hajiaghaee R, Norian R, Aghaei H, Saraei M, Alipour M. 2017. Evaluating the effect of Myrtus communis on programmed cell death in hydatid cyst protoscolices. Asian Pacific Journal of Tropical Medicine, 10(11), 1072–1076. [CrossRef] [PubMed] [Google Scholar]
  44. Sharafi SM, Sefiddashti RR, Sanei B, Yousefi M, Darani HY. 2017. Scolicidal agents for protoscolices of Echinococcus granulosus hydatid cyst: review of literature. Journal of Research in Medical Sciences, 22, 92. [CrossRef] [Google Scholar]
  45. Sharma RK, Parameswaran S. 2018. Calmodulin-binding proteins: a journey of 40 years. Cell Calcium, 75, 89–100. [CrossRef] [PubMed] [Google Scholar]
  46. Shi H, Lei Y, Wang B, Wang Z, Xing G, Lv H, Jiang Y. 2016. Protoscolicidal effects of chenodeoxycholic acid on protoscoleces of Echinococcus granulosus. Experimental Parasitology, 167, 76–82. [CrossRef] [PubMed] [Google Scholar]
  47. Siles-Lucas M, Casulli A, Cirilli R, Carmena D. 2018. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets. PLoS Neglected Tropical Diseases, 12(4), e0006422. [CrossRef] [PubMed] [Google Scholar]
  48. Siracusano A, Delunardo F, Teggi A, Ortona E. 2012. Cystic echinococcosis: aspects of immune response, immunopathogenesis and immune evasion from the human host. Endocrine, Metabolic & Immune Disorders-Drug Targets, 12(1), 16–23. [CrossRef] [Google Scholar]
  49. Siracusano A, Riganò R, Ortona E, Profumo E, Margutti P, Buttari B, Delunardo F, Teggi A. 2008. Immunomodulatory mechanisms during Echinococcus granulosus infection. Experimental Parasitology, 119(4), 483–489. [CrossRef] [PubMed] [Google Scholar]
  50. Spotin A, Mahami-Oskouei M, Harandi MF, Baratchian M, Bordbar A, Ahmadpour E, Ebrahimi S. 2017. Genetic variability of Echinococcus granulosus complex in various geographical populations of Iran inferred by mitochondrial DNA sequences. Acta Tropica, 165, 10–16. [CrossRef] [PubMed] [Google Scholar]
  51. Spotin A, Majdi MMA, Sankian M, Varasteh A. 2012. The study of apoptotic bifunctional effects in relationship between host and parasite in cystic echinococcosis: a new approach to suppression and survival of hydatid cyst. Parasitology Research, 110(5), 1979–1984. [CrossRef] [PubMed] [Google Scholar]
  52. Thompson R. 2017. Biology and systematics of Echinococcus. Advances in Parasitology, 65–109. [CrossRef] [PubMed] [Google Scholar]
  53. Topalian SL, Drake CG, Pardoll DM. 2012. Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity. Current Opinion in Immunology, 24(2), 207–212. [CrossRef] [PubMed] [Google Scholar]
  54. Tsai IJ, Zarowiecki M, Holroyd N, Garciarrubio A, Sanchez-Flores A, Brooks KL, Tracey A, Bobes RJ, Fragoso G, Sciutto E. 2013. The genomes of four tapeworm species reveal adaptations to parasitism. Nature, 496(7443), 57–63. [CrossRef] [PubMed] [Google Scholar]
  55. Tsujimoto Y, Shimizu S. 2005. Another way to die: autophagic programmed cell death. Cell Death & Differentiation, 12, 1528–1534. [CrossRef] [Google Scholar]
  56. Wang N, Zhong X, Song X, Gu X, Lai W, Xie Y, Peng X, Yang G. 2017. Molecular and biochemical characterization of calmodulin from Echinococcus granulosus. Parasites & Vectors, 10(1), 597. [CrossRef] [PubMed] [Google Scholar]
  57. Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP. 2019. Echinococcosis: advances in the 21st century. Clinical Microbiology Reviews, 32(2), e00075–18. [Google Scholar]
  58. Yetim I, Erzurumlu K, Hokelek M, Baris S, Dervisoglu A, Polat C, Belet U, Buyukkarabacak Y, Guvenli A. 2005. Results of alcohol and albendazole injections in hepatic hydatidosis: experimental study. Journal of Gastroenterology and Hepatology, 20(9), 1442–1447. [CrossRef] [PubMed] [Google Scholar]
  59. Zhong X, Song X, Wang N, Hu D, Liu T, Wang T, Gu X, Lai W, Peng X, Yang G. 2016. Molecular identification and characterization of prohibitin from Echinococcus granulosus. Parasitology Research, 115(2), 897–902. [CrossRef] [PubMed] [Google Scholar]

Cite this article as: Moghaddam SM, Picot S & Ahmadpour E. 2019. Interactions between hydatid cyst and regulated cell death may provide new therapeutic opportunities. Parasite 26, 70.

All Tables

Table 1

Cell death and host defense in hydatid cysts.

In the text

All Figures

thumbnail Figure 1

A summary of the potential mechanisms of cell death induced by Echinococcus spp. larval stage. The main molecules involved in cell death are shown, and the three main paths are shown with bold arrows. Directions for stimulation of necrosis, apoptosis and autophagy are shown. In the process of cell death caused by Echinococcus spp., apoptosis plays an important role in the cytolysis of the involved tissues. They can activate both extrinsic and intrinsic pathways. For example, some of them motivate mitochondria to release cytochrome C and P53, resulting in the formation of apoptosomes and activation of Caspase-3.
In the text

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.